Cannabix Technologies Inc. (FRA:8CT)

Cannabix Technologies Income Statement

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Cost of Revenue	0.08	-	-	-	-	6.6
Gross Profit	0.05	-	-	-	-	-6.6
Selling, General & Admin	1.92	1.84	1.72	0.73	1.85	1.4
Research & Development	3.73	2.58	1.24	1.28	1.26	1.1
Operating Expenses	6.21	4.59	3.11	2.14	3.14	2.53
Operating Income	-6.17	-4.59	-3.11	-2.14	-3.14	-9.13
Interest Expense	-0.01	-0.01	-0.02	-0.04	-	-
Interest & Investment Income	0.06	0.1	0.2	0.18	0.03	0.07
Other Non Operating Income (Expenses)	-0.18	-0.17	-0.19	-0.14	-0.25	-0.18
EBT Excluding Unusual Items	-6.3	-4.66	-3.13	-2.14	-3.37	-9.24
Gain (Loss) on Sale of Assets	-0.02	-0.02	-	-	-	-
Pretax Income	-6.32	-4.69	-3.13	-2.14	-3.37	-9.24
Earnings From Continuing Operations	-6.32	-4.69	-3.13	-2.14	-3.37	-9.24
Net Income	-6.32	-4.69	-3.13	-2.14	-3.37	-9.24
Net Income to Common	-6.32	-4.69	-3.13	-2.14	-3.37	-9.24
Shares Outstanding (Basic)	117	115	114	114	114	107
Shares Outstanding (Diluted)	117	115	114	114	114	107
Shares Change (YoY)	2.47%	0.84%	-	0.08%	6.46%	2.43%
EPS (Basic)	-0.05	-0.04	-0.03	-0.02	-0.03	-0.09
EPS (Diluted)	-0.05	-0.04	-0.03	-0.02	-0.03	-0.09
Free Cash Flow	-2.05	-1.86	-2.11	-2	-2.13	-1.79
Free Cash Flow Per Share	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02
EBITDA	-6.14	-4.55	-3.08	-2.01	-3.11	-9.11
D&A For EBITDA	0.03	0.03	0.03	0.13	0.03	0.03
EBIT	-6.17	-4.59	-3.11	-2.14	-3.14	-9.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.